Insights

Growing Market Presence VectorBuilder's extensive global footprint with branches across North America, Europe, Asia, and Australia highlights a strong international customer base of over 50,000 organizations, presenting opportunities to tailor solutions for diverse regional research and clinical needs.

Recognition & Leadership Recent awards such as the IMAPAC Excellence Awards and BioIndustrial Innovation of the Year underscore VectorBuilder's reputation as an innovative leader in gene therapy and biopharmaceutical manufacturing, making it a strategic partner for clients seeking cutting-edge gene delivery solutions.

Innovative Technology The launch of VectorBee and integration with EurekaBio demonstrate VectorBuilder's commitment to advancing research tools and manufacturing efficiencies, creating opportunities to upsell enhanced software solutions and scalable viral vector services to research labs and biotech firms.

Expanding Collaborations Partnerships with companies like Pharmabiz and Lantu Biopharma indicate a focus on developing novel gene therapies and clinical programs, opening avenues to offer customized development, manufacturing, and clinical trial support for emerging gene therapy products.

Focus on Cost Reduction Collaborations aimed at reducing viral vector production costs suggest a strategic push towards making cell and gene therapies more accessible, presenting sales opportunities to provide cost-efficient manufacturing and process development services for pharmaceutical and biotech clients.

VectorBuilder Tech Stack

VectorBuilder uses 8 technology products and services including Linkedin Insight Tag, Google Ads Conversion Tracking, Cart Functionality, and more. Explore VectorBuilder's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • Google Ads Conversion Tracking
    Analytics
  • Cart Functionality
    E-commerce
  • Moment.js
    Javascript Libraries
  • vBulletin
    Message Boards
  • Google Tag Manager
    Tag Management
  • GoDaddy
    Web Hosting
  • Nginx
    Web Servers

Media & News

VectorBuilder's Email Address Formats

VectorBuilder uses at least 1 format(s):
VectorBuilder Email FormatsExamplePercentage
FirstLast@vectorbuilder.comJohnDoe@vectorbuilder.com
87%
FirstLas@vectorbuilder.comJohnDoe@vectorbuilder.com
5%
First.Last@vectorbuilder.comJohn.Doe@vectorbuilder.com
4%
FirLast@vectorbuilder.comJohDoe@vectorbuilder.com
4%

Frequently Asked Questions

Where is VectorBuilder's headquarters located?

Minus sign iconPlus sign icon
VectorBuilder's main headquarters is located at 1010 West 35th Street, Suite 515. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is VectorBuilder's official website and social media links?

Minus sign iconPlus sign icon
VectorBuilder's official website is vectorbuilder.com and has social profiles on LinkedInCrunchbase.

What is VectorBuilder's SIC code NAICS code?

Minus sign iconPlus sign icon
VectorBuilder's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does VectorBuilder have currently?

Minus sign iconPlus sign icon
As of December 2025, VectorBuilder has approximately 501 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Head Of Cdmo Business Development: A. A.Head Of Cdmo Global Operations: A. G.Head Of Human Resources: E. S.. Explore VectorBuilder's employee directory with LeadIQ.

What industry does VectorBuilder belong to?

Minus sign iconPlus sign icon
VectorBuilder operates in the Biotechnology Research industry.

What technology does VectorBuilder use?

Minus sign iconPlus sign icon
VectorBuilder's tech stack includes Linkedin Insight TagGoogle Ads Conversion TrackingCart FunctionalityMoment.jsvBulletinGoogle Tag ManagerGoDaddyNginx.

What is VectorBuilder's email format?

Minus sign iconPlus sign icon
VectorBuilder's email format typically follows the pattern of FirstLast@vectorbuilder.com. Find more VectorBuilder email formats with LeadIQ.

When was VectorBuilder founded?

Minus sign iconPlus sign icon
VectorBuilder was founded in 2014.

VectorBuilder

Biotechnology ResearchIllinois, United States501-1000 Employees

As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.

VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy.

We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received glowing customer testimonials and numerous citations in high-impact publications.

Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, Australia and Israel, VectorBuilder has served over 50,000 customers from several thousand organization worldwide, including universities, research institutions, biotech/pharma companies, and governmental agencies.

So we ask you one question: Will you join us in the gene delivery revolution?

Section iconCompany Overview

Headquarters
1010 West 35th Street, Suite 515
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
501-1000

Section iconFunding & Financials

  • $10M$25M

    VectorBuilder's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    VectorBuilder's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.